皓元医药：公司工具化合物业务处于优势地位并具备较强的国际影响力

Core Viewpoint - The company, Haoyuan Pharmaceutical, asserts its competitive advantage in the tool compound business and strong international influence, while also integrating its recombinant protein and biochemical reagent businesses to enhance resource efficiency and market synergy [1] Business Overview - The tool compound and biochemical reagent segment is presented as a combined performance metric in financial disclosures, indicating a strategic alignment of these business areas [1] - The company has committed to increasing research and development in the biochemical reagent sector, with over 23,000 types of biopolymer products, including recombinant proteins, antibodies, and enzymes, developed by the end of Q3 2025 [1]